Volume of the hippocampal subfields in healthy adults: differential associations with age and a pro-inflammatory genetic variant

Brain Structure and Function

Volumn 220, Issue 5, 2015, Pages 2663-2674

  Raz, Naftali ^a   Daugherty, Ana M ^a   Bender, Andrew R ^b   Dahle, Cheryl L ^b   Land, Susan ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

APOE; Brain; CA1; Hypertension; IL 1beta; IL 6

Indexed keywords

APOLIPOPROTEIN E4; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ADULT; AGE; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MALE; MEDIAL TEMPORAL LOBE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; SUBICULUM; AGED; AGING; GENETICS; INFLAMMATION; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; FEMALE; HIPPOCAMPUS; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84940599158     PISSN: 18632653     EISSN: 18632661     Source Type: Journal    
DOI: 10.1007/s00429-014-0817-6     Document Type: Article

References (109)

1. Adamson M, Landy KM, Duong S, Fox-Bosetti S, Ashford JW, Murphy GM, Weiner M, Taylor JL (2010) Apolipoprotein E epsilon4 influences on episodic recall and brain structures in aging pilots. Neurobiol Aging 31:1059–1063. doi:10.1016/j.neurobiolaging.2008.07.017
2. Arisi GM (2014) Nervous and immune systems signals and connections: cytokines in hippocampus physiology and pathology. Epilepsy Behav. doi:10.1016/j.yebeh.2014.01.017
3. Ban E, Milon G, Prudhomme N, Fillion G, Haour F (1991) Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience 43:21–30
4. Banks WA (2005) Blood–brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des 11:973–984
5. Banks WA, Kastin AJ, Broadwell RD (1995) Passage of cytokines across the blood–brain barrier. Neuroimmunomodulation 2:241–248
6. Banks WA, Farr SA, La Scola ME, Morley JE (2001) Intravenous human interleukin-1 alpha impairs memory processing in mice: dependence on blood–brain barrier transport into posterior division of the septum. J Pharmacol Exp Ther 299:536–541
7. Bartsch T, Döhring J, Rohr A, Jansen O, Deuschl G (2011) CA1 neurons in the human hippocampus are critical for autobiographical memory, mental time travel, and autonoetic consciousness. Proc Natl Acad Sci USA 108:17562–17567. doi:10.1073/pnas.1110266108
8. Baune BT, Konrad C, Grotegerd D, Suslow T, Birosova E, Ohrmann P, Bauer J, Arolt V, Heindel W, Domschke K, Schöning S, Rauch AV, Uhlmann C, Kugel H, Dannlowski U (2012) Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain. J Neuroinflamm 9:125. doi:10.1186/1742-2094-9-125
9. Bender AR, Raz N (2012) Age-related differences in memory and executive functions in healthy APOE ε4 carriers: the contribution of individual differences in prefrontal volumes and systolic blood pressure. Neuropsychologia 50:704–714. doi:10.1016/j.neuropsychologia.2011.12.025
10. Blasko I, Stampfer-Kountchev M, Robatscher P, Veerhuis R, Eikelenboom P, Grubeck-Loebenstein B (2004) How chronic inflammation can affect the brain and support the development of Alzheimer’s disease in old age: the role of microglia and astrocytes. Aging Cell 3:169–176
11. Bobinski M, de Leon MJ, Wegiel J, Desanti S, Convit A, Saint Louis LA, Rusinek H, Wisniewski HM (2000) The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer’s disease. Neuroscience 95:721–725
12. Burns JM, Honea RA, Vidoni ED, Hutfles LJ, Brooks WM, Swerdlow RH (2012) Insulin is differentially related to cognitive decline and atrophy in Alzheimer’s disease and aging. Biochim Biophys Acta 1822:333–339. doi:10.1016/j.bbadis.2011.06.011
13. Cherbuin N, Anstey KJ, Sachdev PS, Maller JJ, Meslin C, Mack HA, Wen W, Easteal S (2008) Total and regional gray matter volume is not related to APOE*E4 status in a community sample of middle-aged individuals. J Gerontol A Biol Sci Med Sci 63:501–504
14. Cherbuin N, Sachdev P, Anstey KJ (2012) Higher normal fasting plasma glucose is associated with hippocampal atrophy: the PATH Study. Neurology 79:1019–1026. doi:10.1212/WNL.0b013e31826846de
15. Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Thompson PM, Reiman EM, Jack CR Jr, Fox NC, Jagust WJ, Harvey DJ, Beckett LA, Gamst A, Aisen PS, Petersen RC, Weiner MW, Alzheimer’s Disease Neuroimaging Initiative (2011) Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment. Alzheimers Dement 7:514–520. doi:10.1016/j.jalz.2010.12.010
16. Cohen RM, Small C, Lalonde F, Friz J, Sunderland T (2001) Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology 57:2223–2228
17. Crivello F, Lemaître H, Dufouil C, Grassiot B, Delcroix N, Tzourio-Mazoyer N, Tzourio C, Mazoyer B (2010) Effects of ApoE-epsilon4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons. Neuroimage 53:1064–1069. doi:10.1016/j.neuroimage.2009.12.116
18. Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1–21
19. den Heijer T, Vermeer SE, Clarke R, Oudkerk M, Koudstaal PJ, Hofman A, Breteler MM (2003) Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 126:170–175
20. den Heijer T, van der Lijn F, Ikram A, Koudstaal PJ, van der Lugt A, Krestin GP, Vrooman HA, Hofman A, Niessen WJ, Breteler MM (2012) Vascular risk factors, apolipoprotein E, and hippocampal decline on magnetic resonance imaging over a 10-year follow-up. Alzheimers Dement 8:417–425. doi:10.1016/j.jalz.2011.07.005
21. Di Bona D, Plaia A, Vasto S, Cavallone L, Lescai F, Franceschi C, Licastro F, Colonna-Romano G, Lio D, Candore G, Caruso C (2008) Association between the interleukin-1beta polymorphisms and Alzheimer’s disease: a systematic review and meta-analysis. Brain Res Rev 59:155–163. doi:10.1016/j.brainresrev.2008.07.003
22. Di Filippo M, Chiasserini D, Gardoni F, Viviani B, Tozzi A, Giampà C, Costa C, Tantucci M, Zianni E, Boraso M, Siliquini S, de lure A, Ghiglieri V, Colcelli E, Baker D, Sarchielli P, Fusco FR, Di Luca M, Calabresi P (2013) Effects of central and peripheral inflammation on hippocampal synaptic plasticity. Neurobiol Dis 52:229–236. doi:10.1016/j.nbd.2012.12.009
23. Ekdahl CT, Kokaia Z, Lindvall O (2009) Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 158:1021–1029. doi:10.1016/j.neuroscience.2008.06.052
24. Ferencz B, Laukka EJ, Lövdén M, Kalpouzos G, Keller L, Graff C, Wahlund LO, Fratiglioni L, Bäckman L (2013) The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age. Front Hum Neurosci 7:198. doi:10.3389/fnhum.2013.00198
25. Finch CE, Crimmins EM (2004) Inflammatory exposure and historical changes in human life-spans. Science 305:1736–1739
26. Finch CE, Foster JR, Mirsky AE (1969) Ageing and the regulation of cell activities during exposure to cold. J Gen Physiol 54:690–712
27. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
28. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254
29. Franklin SS, Gustin WT, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D (1997) Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 96:308–315
30. Gomes da Silva S, Simões PS, Mortara RA, Scorza FA, Cavalheiro EA, da Graça Naffah-Mazzacoratti M, Arida RM (2013) Exercise-induced hippocampal anti-inflammatory response in aged rats. J Neuroinflammation 10:61. doi:10.1186/1742-2094-10-61
31. Graeber MB, Li W, Rodriguez MI (2011) Role of microglia in CNS inflammation. FEBS Lett 585:3798–3805
32. Grammas P (2011) Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer’s disease. J Neuroinflamm 8:26. doi:10.1186/1742-2094-8-26
33. Griffin WS, Mrak RE (2002) Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer’s disease. J Leukoc Biol 72:233–238
34. Guo JT, Yu J, Grass D, de Beer FC, Kindy MS (2002) Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J Neurosci 22:5900–5909
35. Harry GJ, d’Hellencourt CL (2003) Dentate gyrus: alterations that occur with hippocampal injury. Neurotoxicology 24:343–356
36. Hauss-Wegrzyniak B, Galons JP, Wenk GL (2000) Quantitative volumetric analyses of brain magnetic resonance imaging from rat with chronic neuroinflammation. Exp Neurol 165:347–354
37. Hayes A, Green EK, Pritchard A, Harris JM, Zhang Y, Lambert JC, Chartier-Harlin MC, Pickering-Brown SM, Lendon CL, Mann DM (2004) A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 75:1475–1477
38. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA (2007) Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health 7:220
39. Hof PR, Morrison JH (1996) Hippocampal and neocortical involvement in normal brain aging and dementia: morphological and neurochemical profile of the vulnerable circuits. J Am Geriatr Soc 44:857–864
40. Hostage CA, Roy Choudhury K, Doraiswamy PM, Petrella JR, Alzheimer’s Disease Neuroimaging Initiative (2013) Dissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer’s disease. PLoS One 8:e54483. doi:10.1371/journal.pone.0054483
41. Huang ZB, Sheng GQ (2010) Interleukin-1beta with learning and memory. Neurosci Bull 26:455–468
42. Hurme M, Santtila S (1998) IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes. Eur J Immunol 28:2598–2602
43. Jenkinson M, Pechaud M, Smith S (2005) BET2: MR-based estimation of brain, skull and scalp surfaces. In: The Proceedings from the eleventh annual meeting of the organization for human brain mapping, Toronto, Ontario, Canada
44. Jurgens HA, Johnson RW (2012) Dysregulated neuronal-microglial cross-talk during aging, stress and inflammation. Exp Neurol 233:40–48. doi:10.1016/j.expneurol.2010.11.014
45. Katan MB (1986) Apolipoprotein E isoforms, serum cholesterol, and cancer. Lancet 1:507–508
46. Kauffman MA, Moron DG, Consalvo D, Bello R, Kochen S (2008) Association study between interleukin 1 beta gene and epileptic disorders: a HuGe review and meta-analysis. Genet Med 10:83–88. doi:10.1097/GIM.0b013e318161317c
47. Keihaninejad S, Heckemann RA, Fagiolo G, Symms MR, Hajnal JV, Hammers A (2010) A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T). Neuroimage 50:1427–1437. doi:10.1016/j.neuroimage.2010.01.064
48. Kerchner GA, Bernstein JD, Fenesy MC, Deutsch GK, Saranathan M, Zeineh MM, Rutt BK (2013) Shared vulnerability of two synaptically-connected medial temporal lobe areas to age and cognitive decline: a seven tesla magnetic resonance imaging study. J Neurosci 33:16666–16672. doi:10.1523/JNEUROSCI.1915-13.2013
49. Kesner RP (2007) Behavioral functions of the CA3 subregion of the hippocampus. Learn Mem 14:771–781
50. Konsman JP, Kelley K, Dantzer R (1999) Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain. Neuroscience 89:535–548
51. Koo JW, Duman RS (2008) IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci USA 105:751–756. doi:10.1073/pnas.0708092105
52. Korf ES, White LR, Scheltens P, Launer LJ (2004) Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension 44:29–34
53. Kriz J, Lalancette-Hébert M (2009) Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol 117:497–509. doi:10.1007/s00401-009-0496-1
54. La Joie R, Fouquet M, Mézenge F, Landeau B, Villain N, Mevel K, Pélerin A, Eustache F, Desgranges B, Chételat G (2010) Differential effect of age on hippocampal subfields assessed using a new high-resolution 3T MR sequence. Neuroimage 53:506–514. doi:10.1016/j.neuroimage.2010.06.024
55. Lawlor DA, Harbord RM, Sternej AC, Timpson N, Davey Smith G (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27:1133–1163
56. Lee JW, Lee YK, Yuk DY, Choi DY, Ban SB, Oh KW, Hong JT (2008) Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflamm 5:37. doi:10.1186/1742-2094-5-37
57. Lemaître H, Crivello F, Dufouil C, Grassiot B, Tzourio C, Alpérovitch A, Mazoyer B (2005) No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. Neuroimage 24:1205–1213
58. Lind J, Larsson A, Persson J, Ingvar M, Nilsson LG, Bäckman L, Adolfsson R, Cruts M, Sleegers K, Van Broeckhoven C, Nyberg L (2006) Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Neurosci Lett 396:23–27
59. Liu X, Wu Z, Hayashi Y, Nakanishi H (2012) Age-dependent neuroinflammatory responses and deficits in long-term potentiation in the hippocampus during systemic inflammation. Neuroscience 216:133–142. doi:10.1016/j.neuroscience.2012.04.050
60. Lu PH, Thompson PM, Leow A, Lee GJ, Lee A, Yanovsky I, Parikshak N, Khoo T, Wu S, Geschwind D, Bartzokis G (2011) Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study. J Alzheimers Dis 23:433–442. doi:10.3233/JAD-2010-101398
61. Lynch MA (1998) Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukin-1 beta? Prog Neurobiol 56:571–589
62. Mahley R (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622–640
63. Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB, Hariri AR (2008) Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry 64:484–490. doi:10.1016/j.biopsych
64. Meisenzahl EM, Rujescu D, Kirner A, Giegling I, Kathmann N, Leinsinger G, Maag K, Hegerl U, Hahn K, Möller HJ (2001) Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia. Am J Psychiatry 158:1316–1319
65. Moffat SD, Szekely CA, Zonderman AB, Kabani NJ, Resnick SM (2000) Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology 55:134–136
66. Mu Q, Xie J, Wen Z, Weng Y, Shuyun Z (1999) A quantitative MR study of the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle in healthy subjects 40 to 90 years of age. AJNR Am J Neuroradiol 20:207–211
67. Mueller SG, Weiner MW (2009) Selective effect of age, Apo e4, and Alzheimer’s disease on hippocampal subfields. Hippocampus 19:558–564. doi:10.1002/hipo.20614
68. Mueller SG, Stables L, Du AT, Schuff N, Truran D, Cashdollar N, Weiner MW (2007) Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4T. Neurobiol Aging 28:719–726
69. Mueller SG, Chao LL, Berman B, Weiner MW (2011) Evidence for functional specialization of hippocampal subfields detected by MR subfield volumetry on high resolution images at 4T. Neuroimage 56:851–857. doi:10.1016/j.neuroimage.2011.03.028
70. Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97–113
71. Papiol S, Molina V, Desco M, Rosa A, Reig S, Gispert JD, Sanz J, Palomo T, Fañanás L (2005) Ventricular enlargement in schizophrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene. Neuroimage 27:1002–1006
72. Papiol S, Molina V, Desco M, Rosa A, Reig S, Sanz J, Palomo T, Fañanás L (2008) Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin-1 beta gene (2q13). Genes Brain Behav 7:796–801. doi:10.1111/j.1601-183X.2008.00421.x
73. Pedra JH, Cassel SL, Sutterwala FS (2009) Sensing pathogens and danger signals by the inflammasome. Curr Opin Immunol 21:10–16. doi:10.1016/j.coi.2009.01.006
74. Pereira JB, Valls-Pedret C, Ros E, Palacios E, Falcón C, Bargalló N, Bartrés-Faz D, Wahlund LO, Westman E, Junque C (2014) Regional vulnerability of hippocampal subfields to aging measured by structural and diffusion MRI. Hippocampus 24:403–414. doi:10.1002/hipo.22234
75. Petito CK, Pulsinelli WA (1984) Delayed neuronal recovery and neuronal death in rat hippocampus following severe cerebral ischemia: possible relationship to abnormalities in neuronal processes. J Cereb Blood Flow Metab 4:194–205
76. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ (2005) Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of Professional and Public Education of the American Heart Association Council on high blood pressure research. Hypertension 45:142–161
77. Pievani M, Galluzzi S, Thompson PM, Rasser PE, Bonetti M, Frisoni GB (2011) APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer’s disease. Neuroimage 55:909–919. doi:10.1016/j.neuroimage.2010.12.081
78. Pulsinelli WA, Waldman S, Rawlinson D, Plum F (1982) Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology 32:1239–1246
79. Qiu C, Zhang Y, Bronge L, Herlitz A, Aspelin P, Bäckman L, Fratiglioni L, Wahlund LO (2012) Medial temporal lobe is vulnerable to vascular risk factors in men: a population-based study. Eur J Neurol 19:876–883. doi:10.1111/j.1468-1331.2011.03645.x
80. Qiu LR, Germann J, Spring S, Alm C, Vousden DA, Palmert MR, Lerch JP (2013) Hippocampal volumes differ across the mouse estrous cycle, can change within 24 hours, and associate with cognitive strategies. Neuroimage 83:593–598. doi:10.1016/j.neuroimage.2013.06.074
81. Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401
82. Rasgon NL, Kenna HA, Wroolie TE, Kelley R, Silverman D, Brooks J, Williams KE, Powers BN, Hallmayer J, Reiss A (2011) Insulin resistance and hippocampal volume in women at risk for Alzheimer’s disease. Neurobiol Aging 32:1942–1948. doi:10.1016/j.neurobiolaging.2009.12.005
83. Ravaglia G, Paola F, Maioli F, Martelli M, Montesi F, Bastagli L, Bianchin M, Chiappelli M, Tumini E, Bolondi L, Licastro F (2006) Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study. Exp Gerontol 41:85–92
84. Raz N (2000) Aging of the brain and its impact on cognitive performance: Integration of structural and functional findings. In: Craik FIM, Salthouse TA (eds) Handbook of aging and cognition—II. Erlbaum, New Jersey, pp 1–90
85. Raz N, Kennedy KM (2009) A systems approach to the aging brain: neuroanatomic changes, their modifiers, and cognitive correlates. In: Jagust W, D’Esposito M (eds) Imaging the aging brain. Oxford University Press, New York, pp 43–70
86. Raz N, Lindenberger U, Rodrigue KM, Kennedy KM, Head D, Williamson A, Dahle C, Gerstorf D, Acker JD (2005) Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb Cortex 15:1676–1689
87. Raz N, Lindenberger U, Ghisletta P, Rodrigue KM, Kennedy KM, Acker JD (2008) Neuroanatomical correlates of fluid intelligence in healthy adults and persons with vascular risk factors. Cereb Cortex 18:718–726
88. Raz N, Yang Y, Dahle CL, Land S (2012) Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants. Biochim Biophys Acta 1822:361–369. doi:10.1016/j.bbadis.2011.08.007
89. Reynolds E (2006) Vitamin B12, folic acid, and the nervous system. Lancet Neurol 5:949–960
90. Richter-Schmidinger T, Alexopoulos P, Horn M, Maus S, Reichel M, Rhein C, Lewczuk P, Sidiropoulos C, Kneib T, Perneczky R, Doerfler A, Kornhuber J (2011) Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults. J Neural Transm 118:249–257. doi:10.1007/s00702-010-0539-8
91. Roses AD (1996) Apolipoprotein E and Alzheimer’s disease. A rapidly expanding field with medical and epidemiological consequences. Ann N Y Acad Sci 802:50–57
92. Satizabal CL, Zhu YC, Mazoyer B, Dufouil C, Tzourio C (2012) Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study. Neurology 78:720–727. doi:10.1212/WNL.0b013e318248e50f
93. Shing YL, Rodrigue KM, Kennedy KM, Fandakova Y, Bodammer N, Werkle-Bergner M, Lindenberger U, Raz N (2011) Hippocampal subfield volumes: age, vascular risk, and correlation with associative memory. Front Aging Neurosci 3:2. doi:10.3389/fnagi.2011.00002
94. Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86:420–428
95. Simi A, Tsakiri N, Wang P, Rothwell NJ (2007) Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans 35:1122–1126
96. Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA (2011) A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci 12:585–601. doi:10.1038/nrn3085
97. Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17:143–155
98. Sugawara T, Lewén A, Noshita N, Gasche Y, Chan PH (2002) Effects of global ischemia duration on neuronal, astroglial, oligodendroglial, and microglial reactions in the vulnerable hippocampal CA1 subregion in rats. J Neurotrauma 19:85–98
99. Sullivan EV, Marsh L, Mathalon DH, Lim KO, Pfefferbaum A (1995) Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus. Neurobiol Aging 16:591–606
100. Suyama K (1992) Changes of neuronal transmission in the hippocampus after transient ischemia in spontaneously hypertensive rats and the protective effects of MK-801. Stroke 23:260–266
101. Troyer AK, Murphy KJ, Anderson ND, Craik FI, Moscovitch M, Maione A, Gao F (2012) Associative recognition in mild cognitive impairment: Relationship to hippocampal volume and apolipoprotein E. Neuropsychologia 50:3721–3728. doi:10.1016/j.neuropsychologia.2012.10.018
102. Tso AR, Merino JG, Warach S (2007) Interleukin-6 174G/C polymorphism and ischemic stroke: a systematic review. Stroke 38:3070–3075
103. van Leemput K, Bakkour A, Benner T, Wiggins G, Wald LL, Augustinack J (2009) Automated segmentation of hippocampal subfields from ultra-high resolution in vivo MRI. Hippocampus 19:549–557
104. Vitkovic L, Konsman JP, Bockaert J, Dantzer R, Homburger V, Jacque C (2000) Cytokine signals propagate through the brain. Mol Psychiatry 5:604–615
105. Williamson LL, Bilbo SD (2013) Chemokines and the hippocampus: a new perspective on hippocampal plasticity and vulnerability. Brain Behav Immun 30:186–194. doi:10.1016/j.bbi.2013.01.077
106. Wills AK, Lawlor DA, Matthews FE, Sayer AA, Bakra E, Ben-Shlomo Y, Benzeval M, Brunner E, Cooper R, Kivimaki M, Kuh D, Muniz-Terrera G, Hardy R (2011) Life course trajectories of systolic blood pressure using longitudinal data from eight UK cohorts. PLoS Med 8:e1000440. doi:10.1371/journal.pmed.1000440
107. Witter MP, Amaral DG (1995) Hippocampal formation. In: Paxinos GT (ed) The rat nervous system, 2nd edn. Academic Press, California, pp 443–493
108. Wolf OT, Dyakin V, Patel A, Vadasz C, de Leon MJ, McEwen BS, Bulloch K (2002) Volumetric structural magnetic resonance imaging (MRI) of the rat hippocampus following kainic acid (KA) treatment. Brain Res 934:87–96
109. Yirmiya R, Goshen I (2011) Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 25:181–213. doi:10.1016/j.bbi.2010.10.015